Dantrolene (sodium hemiheptahydrate)


CAS No. : 24868-20-0

(Synonyms: Dantrolene sodium hydrate)

24868-20-0
Price and Availability of CAS No. : 24868-20-0
Size Price Stock
100mg $60 In-stock
500mg $180 In-stock
1 g Get quote
5 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-12542A
M.Wt: 399.31
Formula: C14H10N4O5.7/2H2O.Na
Purity: >98 %
Solubility: DMSO : ≥ 33 mg/mL;H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 24868-20-0 :

Dantrolene sodium hemiheptahydrate is an orally active, non-competitive glutathione reductase inhibitor with a Ki of 111.6 μM and an IC50 of 52.3 μM. Dantrolene sodium hemiheptahydrate is also a calcium channel protein inhibitor. Dantrolene sodium hemiheptahydrate inhibits the release of Ca2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis (e.g., stroke, ischemia/reperfusion injury, and neurodegenerative diseases). Dantrolene sodium hemiheptahydrate offers relief of muscle spasms, malignant hyperthermia, and antitoxic, antipyretic, and anti-inflammatory properties[1][2][3][4][5][6][7][8][9][10][11]. In Vitro:Dantrolene (50 μM) sodium hemiheptahydrate alleviates malignant hyperthermia by preventing overactive Ca2+ release by increasing the affinity of ryanodine receptor (RyR) for Mg2+ in rat skin fibers[2].
Dantrolene (30 μM, 1 h-3 days) sodium hemiheptahydrate ameliorates the impairment of neurogenesis and synaptogenesis, in association with restoring intracellular Ca2+ homeostasis and physiological autophagy, cell survival and proliferation in induced pluripotent stem cells derived from patients with Alzheimer's disease [3].
Dantrolene (40 μM, 12 h) sodium hemiheptahydrate enhances the protective effect of hypothermia on cerebral cortex neurons, including improved morphology, increased survival and mitochondrial membrane potential, decreased intracellular reactive oxygen species, cytoplasmic histone-associated DNA fragmentation and apoptosis[7].
In Vivo:Dantrolene (5-20 mg/kg, i.v.) sodium hemiheptahydrate exhibits cardioprotective effects in a rat model of Digoxin (HY-B1049)-induced cardiotoxicity[4].
Dantrolene (5-10 mg/kg, i.p.) sodium hemiheptahydrate attenuates spinal cord inflammation in mice with experimental autoimmune encephalomyelitis (EAE) [5].
Dantrolene (5 mg/kg, intranasal or subcutaneous, 3 times per week) sodium hemiheptahydrate improves cognitive dysfunction in 5XFAD Alzheimer's disease (AD) mice [6].

Your information is safe with us.